Rheumatology Network's Top 5: FDA Approvals

Check out rheumatology's most groundbreaking FDA approvals of 2021!

Related Videos
Related Content

C Diff Deaths Increased During COVID-19 Pandemic, Study Finds

September 27th 2023

Recapping RSV's Historic Year & What Comes Next with Barbara Taylor, MD, MS

September 19th 2023

DAA Therapy Associated with SVR Regardless of Alcohol Consumption, Study Finds

September 27th 2023

New Insight: A Look at OPT-302/Sozinibercept with Megan Baldwin, PhD

September 8th 2023

Denosumab Biosimilar LY01011 Demonstrates Safety, Immunogenicity

September 27th 2023

Nearly 4 in 10 Adults with T1D Diagnosed After Age 30 Years, Study Finds

September 26th 2023

C Diff Deaths Increased During COVID-19 Pandemic, Study Finds

September 27th 2023

Recapping RSV's Historic Year & What Comes Next with Barbara Taylor, MD, MS

September 19th 2023

DAA Therapy Associated with SVR Regardless of Alcohol Consumption, Study Finds

September 27th 2023

New Insight: A Look at OPT-302/Sozinibercept with Megan Baldwin, PhD

September 8th 2023

Denosumab Biosimilar LY01011 Demonstrates Safety, Immunogenicity

September 27th 2023

Nearly 4 in 10 Adults with T1D Diagnosed After Age 30 Years, Study Finds

September 26th 2023

C Diff Deaths Increased During COVID-19 Pandemic, Study Finds

September 27th 2023

Recapping RSV's Historic Year & What Comes Next with Barbara Taylor, MD, MS

September 19th 2023

DAA Therapy Associated with SVR Regardless of Alcohol Consumption, Study Finds

September 27th 2023

New Insight: A Look at OPT-302/Sozinibercept with Megan Baldwin, PhD

September 8th 2023

Denosumab Biosimilar LY01011 Demonstrates Safety, Immunogenicity

September 27th 2023

Nearly 4 in 10 Adults with T1D Diagnosed After Age 30 Years, Study Finds

September 26th 2023
© 2023 MJH Life Sciences

All rights reserved.